To amend the Internal Revenue Code of 1986 to provide a 5-year extension for the work opportunity credit and the welfare-to-work credit.

The Guaranteeing Individual Fairness in Transplants Act of 2025 (GIFT Act of 2025) directly amends the conditions for Medicare participation for hospitals, critical access hospitals, and rural emergency hospitals. It specifically prohibits these facilities from considering an individual's vaccination status when determining eligibility for organ transplants. This is a direct regulatory change that imposes a new operational requirement on all hospitals that participate in Medicare, which includes the vast majority of hospitals in the United States. This bill does not involve direct funding or appropriations. Instead, it creates a new compliance obligation. Hospitals failing to adhere to this mandate risk losing their Medicare participation status, which is financially catastrophic for most facilities. The money trail here is indirect: hospitals will need to adjust their transplant protocols, update internal policies, and potentially face increased legal scrutiny or litigation related to transplant decisions. This will lead to increased operational and compliance costs for healthcare providers. Historically, similar mandates on healthcare providers regarding patient treatment criteria have led to increased administrative burdens and compliance costs. For example, the Emergency Medical Treatment and Labor Act (EMTALA) of 1986, which mandated emergency care regardless of ability to pay, significantly increased uncompensated care costs for hospitals. While not directly comparable in scope, the principle of a federal mandate dictating patient care criteria for Medicare participation is similar. The market reaction to EMTALA was a gradual increase in financial pressure on hospitals, rather than an immediate stock market event. This bill, while narrower, imposes a similar type of regulatory constraint. Specific winners are not apparent, as this bill primarily imposes a new requirement. Potential losers include large hospital systems such as HCA Healthcare ($HCA), Universal Health Services ($UHS), Tenet Healthcare ($THC), LifePoint Health, and Community Health Systems ($CYH), which operate numerous Medicare-participating facilities and will bear the brunt of compliance adjustments and potential legal challenges. These companies will incur additional administrative and legal expenses to ensure adherence to the new federal mandate. The bill has been referred to two committees, indicating it is in the early stages of the legislative process. If it progresses, further committee hearings and votes would occur, with potential floor votes in both chambers. This bill is currently in the committee referral stage. The next steps involve committee review and potential markups. Given the sponsor is a junior member, the immediate legislative momentum is moderate, but the policy area (healthcare mandates) often garners significant attention. If passed, the effective date would likely be specified in the bill, typically 6-12 months post-enactment to allow for hospital compliance.